Salentine Thomas J Jr
SEC CIK 2037899 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GRDN | Guardian Pharmacy Services, Inc. | Dir, 10% | 10.57M | $500.0K | $189.85M | 6 | 2024-09-27 | 2026-03-28 |
Most active insiders at GRDN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bindley Capital Partners I, LLC | 10% | — | $105.98M |
| 2 | Salentine Thomas J Jr | Dir, 10% | — | $105.98M |
| 3 | BINDLEY WILLIAM E | Dir, 10% | — | $105.98M |
| 4 | Ackerman John | Dir | — | $32.75M |
| 5 | Pharmacy Investors, LLC | Member of 10% owner group | — | $24.56M |
| 6 | Burke Fred | See Remarks, Dir | — | $19.93M |
| 7 | Forbes Kendall | See Remarks | — | $10.29M |
| 8 | Cardinal Equity Fund, L.P. | Member of 10% owner group | — | $8.18M |
| 9 | Morris David K | See Remarks, Dir | — | $5.58M |
| 10 | COSLER STEVEN D | Dir | $99.8K | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-03-31 | 2026-03-28 | GRDN | Guardian Pharmacy Services, Inc. | Salentine Thomas J Jr | Dir, 10% | M - OptEx | — | +6.10M | 10.57M | +136% | — |
| I | 2026-03-24 | 2026-03-20 | GRDN | Guardian Pharmacy Services, Inc. | Salentine Thomas J Jr | Dir, 10% | S - Sale | $29.68 | -3.57M | 4.47M | -44% | -$105.98M |
| DI | 2025-09-30 | 2025-09-27 | GRDN | Guardian Pharmacy Services, Inc. | Salentine Thomas J Jr | Dir, 10% | M - OptEx | — | +6.10M | 8.04M | +314% | — |
| MI | 2025-05-29 | 2025-05-27+ | GRDN | Guardian Pharmacy Services, Inc. | Salentine Thomas J Jr | Dir, 10% | S - Sale | $20.16 | -4.16M | 1.94M | -68% | -$83.87M |
| DI | 2025-04-01 | 2025-03-28 | GRDN | Guardian Pharmacy Services, Inc. | Salentine Thomas J Jr | Dir | M - OptEx | — | +6.10M | 6.10M | New | — |
| D | 2024-10-01 | 2024-09-27 | GRDN | Guardian Pharmacy Services, Inc. | Salentine Thomas J Jr | Dir | P - Purchase | $14.00 | +35.7K | 35.7K | New | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations